Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-093020
Filing Date
2025-07-02
Accepted
2025-07-02 16:26:46
Documents
2
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3916
2 EX-24 tcrx-ex24.htm EX-24 14065
  Complete submission text file 0000950170-25-093020.txt   19398
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Issuer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
Gruia Gabriela (Reporting) CIK: 0001860326 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40603 | Film No.: 251101561